ARS Pharmaceuticals (SPRY) Retained earnings

annual retained earnings:

-$123.31M+$8.00M(+6.09%)
December 31, 2024

Summary

  • As of today (June 21, 2025), SPRY annual retained earnings is -$123.31 million, with the most recent change of +$8.00 million (+6.09%) on December 31, 2024.
  • During the last 3 years, SPRY annual retained earnings has fallen by -$81.05 million (-191.80%).
  • SPRY annual retained earnings is now -460.15% below its all-time high of -$22.01 million, reached on December 1, 2020.

Performance

SPRY Retained earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSPRYbalance sheet metrics

quarterly retained earnings:

-$157.25M-$33.94M(-27.53%)
March 31, 2025

Summary

  • As of today (June 21, 2025), SPRY quarterly retained earnings is -$157.25 million, with the most recent change of -$33.94 million (-27.53%) on March 31, 2025.
  • Over the past year, SPRY quarterly retained earnings has dropped by -$15.65 million (-11.05%).
  • SPRY quarterly retained earnings is now -272.12% below its all-time high of -$42.26 million, reached on December 1, 2021.

Performance

SPRY quarterly retained earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSPRYbalance sheet metrics

Retained earnings Formula

Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid

SPRY Retained earnings Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+6.1%-11.1%
3 y3 years-191.8%-
5 y5 years-460.1%-272.1%

SPRY Retained earnings Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-191.8%+6.1%-181.2%+9.2%
5 y5-year-460.1%+6.1%-272.1%+9.2%
alltimeall time-460.1%+6.1%-272.1%+9.2%

SPRY Retained earnings History

DateAnnualQuarterly
Mar 2025
-
-$157.25M(+27.5%)
Dec 2024
-$123.31M(-6.1%)
-$123.31M(-28.8%)
Sep 2024
-
-$173.24M(+12.4%)
Jun 2024
-
-$154.11M(+8.8%)
Mar 2024
-
-$141.59M(+7.8%)
Dec 2023
-$131.30M
-$131.30M(+5.8%)
Sep 2023
-
-$124.14M(+13.6%)
DateAnnualQuarterly
Jun 2023
-
-$109.27M(+18.9%)
Mar 2023
-
-$91.90M(+19.4%)
Dec 2022
-$76.94M(+82.1%)
-$76.94M(+37.6%)
Jun 2022
-
-$55.93M(+32.4%)
Dec 2021
-$42.26M(+92.0%)
-
Dec 2021
-
-$42.26M
Dec 2020
-$22.01M
-

FAQ

  • What is ARS Pharmaceuticals annual retained earnings?
  • What is the all time high annual retained earnings for ARS Pharmaceuticals?
  • What is ARS Pharmaceuticals annual retained earnings year-on-year change?
  • What is ARS Pharmaceuticals quarterly retained earnings?
  • What is the all time high quarterly retained earnings for ARS Pharmaceuticals?
  • What is ARS Pharmaceuticals quarterly retained earnings year-on-year change?

What is ARS Pharmaceuticals annual retained earnings?

The current annual retained earnings of SPRY is -$123.31M

What is the all time high annual retained earnings for ARS Pharmaceuticals?

ARS Pharmaceuticals all-time high annual retained earnings is -$22.01M

What is ARS Pharmaceuticals annual retained earnings year-on-year change?

Over the past year, SPRY annual retained earnings has changed by +$8.00M (+6.09%)

What is ARS Pharmaceuticals quarterly retained earnings?

The current quarterly retained earnings of SPRY is -$157.25M

What is the all time high quarterly retained earnings for ARS Pharmaceuticals?

ARS Pharmaceuticals all-time high quarterly retained earnings is -$42.26M

What is ARS Pharmaceuticals quarterly retained earnings year-on-year change?

Over the past year, SPRY quarterly retained earnings has changed by -$15.65M (-11.05%)
On this page